The cost of sequencing DNA has plunged from $100 million in 2001 to less than $10,000 today. Amit Bhalla, Citi, offers insight on the developing technologies for personalized care.
Morgan Stanley is moving a hedge fund meeting out of China after a new drug resistant bird flu strain causes 36 deaths, reports CNBC's Michelle Caruso-Cabrera.
In two big M&A deals, Valeant Pharmaceuticals agreed to buy Bausch & Lomb for $8.7 billion, and AstraZeneca agreed to acquire Omthera Pharmaceuticals for as much as $443 million.
Stefan Roever, CEO of Genia, tells CNBC how the company is driving down the cost of gene testing from 1000 to 100 dollars and making the results almost immediate.
A 65-year-old couple retiring this year would need $220,000 on average to cover medical expenses, an 8 percent decrease from last year's estimate. But most people estimate just a fraction of that.
The number of women choosing to have preventive mastectomies has risen by almost 50 percent in recent years, and surveys show they are happy with the decision.
Under President Barack Obama's health care law, where you live could make a huge difference in what you'll pay for medications.
CNBC's Herb Greenberg reports on the question facing Intuitive Surgical. The company alerted hospitals of a potential issue with one of its instruments.
Massachusetts has had Romneycare since 2006. And, while it's different in some ways from Obamacare, it offers insight into what's ahead for US health care.
High frequency trading has become such a hot topic, it's now the subject of a new movie called "Ghost Exchange," with Camilla Sullivan, director of the film.
Following is Cramer's homework on a lesser-known stock called to his attention by viewers.
An antibiotic-resistant strain of gonorrhea has some saying that its effects could match those of AIDS.
With five months until 2014 open enrollment starts, the picture's a little clearer in some of the 16 states that are building their own health exchange marketplaces, with CNBC's Bertha Coombs.
Carlos Slim, joined by five other billionaires, is giving $100 million to the Bill Gates effort to eradicate polio, reports CNBC's Robert Frank.
Novartis was sued on Tuesday by the United States, which accused the Swiss drug maker of using kickbacks to induce pharmacies to steer thousands of patients to its drug.
Amgen's stock fell sharply in after-hours trading after it reported sales that fell short of Wall Street's expectations.
Big pharma is abandoning antibiotic research at a time when fears over superbugs are growing at an alarming rate, leaving smaller firms to fill the breach.
It will take a mix of approaches to make health care more affordable, Johnson & Johnson CEO Alex Gorsky told CNBC.
Most robotic surgery takes place without a hitch, but a growing number of complaints and lawsuits allege complications and even deaths from Intuitive Surgical's da Vinci device.
If the critics of robotic surgery are right—that safety is an issue—how is that it was performed on 450,000 people last year? The answer may lie in one word: Marketing.